Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 0.3999
-1.4001 (-77.78%)
Sep 12, 2025, 5:17 PM CET
Neovacs Market Cap
Neovacs has a market cap or net worth of €94.61 thousand as of September 24, 2025.
Market Cap
94.61K
Enterprise Value
-110.47K
Revenue
433.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.40
Market Cap Chart
Since November 5, 2024, Neovacs's market cap has decreased from 296.00K to 94.61K, a decrease of -68.04%. That is a compound annual growth rate of -72.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2025 | 100.09K | -33.78% |
| Dec 31, 2024 | 151.14K | -48.94% |
| Nov 5, 2024 | 296.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 126.54B |
| Sanofi | 96.44B |
| Sartorius Stedim Biotech | 18.21B |
| bioMérieux | 13.48B |
| Eurofins Scientific SE | 11.09B |
| Ipsen | 9.37B |
| ABIVAX Société Anonyme | 5.31B |
| Virbac | 2.63B |